申请人:Modema Therapeutics, Inc.
                            
                            
                                公开号:US20140371302A1
                            
                            
                                公开(公告)日:2014-12-18
                            
                            This invention relates to modified nucleic acid compositions encoding cell-penetrating polypeptides to provoke an innate immune response in a cell and methods of delivering protein-binding partners to target cells.